Figures & data
Figure 1 Patient flow chart.
Abbreviations: cART, antiretroviral therapy; LFU, lost to follow-up; PEP, post exposure prophylaxis.
![Figure 1 Patient flow chart.](/cms/asset/c31dbd1a-e10d-4283-acb5-6a76565b31e0/dpor_a_127974_f0001_c.jpg)
Figure 2 Use of antiretroviral drugs in the cohort.
Abbreviations: ABC, abacavir; INI, integrase inhibitor; NNRTI, non-nucleoside reverse transcriptase inhibitor; PI/r, protease inhibitor; TDF, tenofovir.
![Figure 2 Use of antiretroviral drugs in the cohort.](/cms/asset/802c3eb7-c491-4357-9c66-c7b3cd75554a/dpor_a_127974_f0002_b.jpg)
Figure 3 Virological response over time.
Note: Proportion of patients below a given threshold (HIV-RNA copies/mL).
![Figure 3 Virological response over time.](/cms/asset/ab29421b-aad6-4134-8edf-88416abd6bde/dpor_a_127974_f0003_b.jpg)
Figure 4 Type of adherence and virological response.
Notes: Patients were grouped according to HIV-RNA over time as K<3: constantly <3 copies/mL; V<3: sometimes below or above the cutoff limit but always <50 copies/mL; K>3: constantly between 3 and 50 copies/mL; and V>50: a measure of >50 copies/mL minimum.
![Figure 4 Type of adherence and virological response.](/cms/asset/528fbc4c-262d-416d-8f1f-37ef13288571/dpor_a_127974_f0004_b.jpg)